[Secondary diabetes in childhood].
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D001215:Asparaginase / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000209:etiology* / Q000503:physiopathology; D003923:Diabetes Mellitus, Lipoatrophic / Q000503:physiopathology; D004314:Down Syndrome / Q000150:complications; D004700:Endocrine System Diseases / Q000150:complications; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D008297:Male; D009765:Obesity / Q000503:physiopathology; D011241:Prednisone / Q000009:adverse effects
D000970:Antineoplastic Agents; D001215:Asparaginase; D011241:Prednisone